INNOVADERM CRO IS NOW INDERO.

Unlocking the Market Potential of Medical Aesthetics

The medical aesthetics industry is an increasingly lucrative and rapidly developing sector of healthcare, currently valued at $13.9 billion and expected to reach a total of $23.4 billion by 2027. Despite this enticing profit potential, developers must consider the numerous challenges and emerging trends that will shape the future of this market.   The Current State of the Medical Aesthetics Market  The […]

Developing Dermal Fillers and Neuromodulators for Aesthetic Indications

Table of Contents Key protocol considerations for development of dermal fillers 1. Safety First 2. Effectiveness 3. Inclusion and Exclusion Criteria 4. Control Options 5. Safety Assessment 6. Effectiveness Assessments 7. Repeated Treatments   Dermal fillers, also known as injectable implants, soft tissue fillers, or wrinkle fillers have been on the medical aesthetic market for over 30 years and have a variety of specific […]

Enhancing the Quality of Clinical Trial Data With 3D Photography

As the medical aesthetic market experiences robust growth, its accompanying technologies continue to evolve. Aesthetic trials use validated scales to evaluate the severity and improvement of a given condition in order to support efficacy endpoints. These evaluations are often performed as live local assessments at the site. However, as objective as these scales aim to be, these […]

Conducting a Successful Medical Aesthetic Trial—Expert Strategies

Table of contents Key components to maximize a trial’s success 1. Site Selection and Patient Engagement 2. Open Communication With Key Stakeholders 3. Prioritization of the Quality of Collected Data and Outcomes  4. Novel Treatments Generate Interest   The medical aesthetic market presents itself as a dynamic frontier with immense possibilities. Site selection, patient enrollment optimization, proper collection of relevant data, […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.